Mast cells control lung type 2 inflammation via prostaglandin E2-driven soluble ST2
Limiting IL-33-driven lung inflammation is a promising means of controlling asthma. Alhallak et al. demonstrate that prostaglandin E2 modulates airway mucosal mast cells and enhances their production of soluble ST2 (IL-33 receptor) to limit asthma-asso…